173 related articles for article (PubMed ID: 18431572)
1. Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4.
Zhang ZY; King BM; Pelletier RD; Wong YN
Cancer Chemother Pharmacol; 2008 Sep; 62(4):707-16. PubMed ID: 18431572
[TBL] [Abstract][Full Text] [Related]
2. Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects.
Li Y; Ning J; Wang Y; Wang C; Sun C; Huo X; Yu Z; Feng L; Zhang B; Tian X; Ma X
Toxicol Lett; 2018 Sep; 294():27-36. PubMed ID: 29753067
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
4. The Impact of the Hepatocyte-to-Plasma pH Gradient on the Prediction of Hepatic Clearance and Drug-Drug Interactions for CYP2C9 and CYP3A4 Substrates.
Rougée LRA; Mohutsky MA; Bedwell DW; Ruterbories KJ; Hall SD
Drug Metab Dispos; 2017 Sep; 45(9):1008-1018. PubMed ID: 28679672
[TBL] [Abstract][Full Text] [Related]
5. Icotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene Intermediate.
Sun C; Zhao H; Li W; Jia Y; Yang Y; Peng Y; Zheng J
Drug Metab Dispos; 2021 Oct; 49(10):892-901. PubMed ID: 34312304
[TBL] [Abstract][Full Text] [Related]
6. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
[TBL] [Abstract][Full Text] [Related]
7. Levomepromazine and clozapine induce the main human cytochrome P450 drug metabolizing enzyme CYP3A4.
Danek PJ; Basińska-Ziobroń A; Wójcikowski J; Daniel WA
Pharmacol Rep; 2021 Feb; 73(1):303-308. PubMed ID: 32888176
[TBL] [Abstract][Full Text] [Related]
8. VX-509 (Decernotinib)-Mediated CYP3A Time-Dependent Inhibition: An Aldehyde Oxidase Metabolite as a Perpetrator of Drug-Drug Interactions.
Zetterberg C; Maltais F; Laitinen L; Liao S; Tsao H; Chakilam A; Hariparsad N
Drug Metab Dispos; 2016 Aug; 44(8):1286-95. PubMed ID: 27298338
[TBL] [Abstract][Full Text] [Related]
9. Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
Chanteux H; Rosa M; Delatour C; Nicolaï J; Gillent E; Dell'Aiera S; Ungell AL
Drug Metab Dispos; 2020 Sep; 48(9):778-787. PubMed ID: 32532738
[TBL] [Abstract][Full Text] [Related]
10. Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies.
Niwa T; Okamoto A; Narita K; Toyota M; Kato K; Kobayashi K; Sasaki S
Arch Biochem Biophys; 2020 Mar; 682():108283. PubMed ID: 32001245
[TBL] [Abstract][Full Text] [Related]
11. Digging Deeper into CYP3A Testosterone Metabolism: Kinetic, Regioselectivity, and Stereoselectivity Differences between CYP3A4/5 and CYP3A7.
Kandel SE; Han LW; Mao Q; Lampe JN
Drug Metab Dispos; 2017 Dec; 45(12):1266-1275. PubMed ID: 28986474
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis.
Zhao J; Sun T; Wu JJ; Cao YF; Fang ZZ; Sun HZ; Zhu ZT; Yang K; Liu YZ; Gonzalez FJ; Yin J
Fitoterapia; 2017 Jun; 119():26-31. PubMed ID: 28344076
[TBL] [Abstract][Full Text] [Related]
13. Functional Characterization of 40 CYP3A4 Variants by Assessing Midazolam 1'-Hydroxylation and Testosterone 6
Kumondai M; Gutiérrez Rico EM; Hishinuma E; Ueda A; Saito S; Saigusa D; Tadaka S; Kinoshita K; Nakayoshi T; Oda A; Abe A; Maekawa M; Mano N; Hirasawa N; Hiratsuka M
Drug Metab Dispos; 2021 Mar; 49(3):212-220. PubMed ID: 33384383
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Novel Renewable Hepatic Cell Model for Prediction of Clinical CYP3A4 Induction Using a Correlation-Based Relative Induction Score Approach.
Zuo R; Li F; Parikh S; Cao L; Cooper KL; Hong Y; Liu J; Faris RA; Li D; Wang H
Drug Metab Dispos; 2017 Feb; 45(2):198-207. PubMed ID: 28062541
[TBL] [Abstract][Full Text] [Related]
15. Identification of enzymes responsible for nitrazepam metabolism and toxicity in human.
Konishi K; Fukami T; Gotoh S; Nakajima M
Biochem Pharmacol; 2017 Sep; 140():150-160. PubMed ID: 28606603
[TBL] [Abstract][Full Text] [Related]
16. Impact of Probe Substrate Selection on Cytochrome P450 Reaction Phenotyping Using the Relative Activity Factor.
Siu YA; Lai WG
Drug Metab Dispos; 2017 Feb; 45(2):183-189. PubMed ID: 27934636
[TBL] [Abstract][Full Text] [Related]
17. beta-caryophyllene oxide and trans-nerolidol affect enzyme activity of CYP3A4 - in vitro and in silico studies.
Špičáková A; Bazgier V; Skálová L; Otyepka M; Anzenbacher P
Physiol Res; 2019 Nov; 68(Suppl 1):S51-S58. PubMed ID: 31755290
[TBL] [Abstract][Full Text] [Related]
18. Muscone Induces CYP1A2 and CYP3A4 Enzyme Expression in L02 Human Liver Cells and CYP1A2 and CYP3A11 Enzyme Expression in Kunming Mice.
Liu S; Cheng Y; Rao M; Tang M; Dong Z
Pharmacology; 2017; 99(5-6):205-215. PubMed ID: 28110334
[TBL] [Abstract][Full Text] [Related]
19. Eribulin mesylate in patients with refractory cancers: a Phase I study.
Mukohara T; Nagai S; Mukai H; Namiki M; Minami H
Invest New Drugs; 2012 Oct; 30(5):1926-33. PubMed ID: 21887501
[TBL] [Abstract][Full Text] [Related]
20. Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel.
Paolini M; Poul L; Berjaud C; Germain M; Darmon A; Bergère M; Pottier A; Levy L; Vibert E
Int J Nanomedicine; 2017; 12():5537-5556. PubMed ID: 28814868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
